L. Aarons, Population pharmacokinetics, Int. J. Clin. Pharmacol. Ther. Toxicol, vol.30, pp.520-522, 1992.

A. C. Atkinson, K. Chaloner, A. M. Herzberg, and J. Juritz, Optimum Experimental Designs for Properties of a Compartmental Model, Biometrics, vol.49, issue.2, pp.325-337, 1993.
DOI : 10.2307/2532547

A. Bailer, An introduction to the use of physiologically based pharmacokinetic models in risk assessment, Statistical Methods in Medical Research, vol.91, issue.4, pp.341-358, 1997.
DOI : 10.1177/096228029700600404

S. L. Beal and L. B. Sheiner, The NONMEM System, The American Statistician, vol.34, issue.2, pp.118-119, 1980.
DOI : 10.2307/2684123

S. L. Beal and L. B. Sheiner, Estimating population kinetics, CRC Crit. Rev. Biomed. Eng, vol.8, pp.195-222, 1982.

D. Beatty and W. Piegorsch, Optimal statistical design for toxicokinetic studies, Statistical Methods in Medical Research, vol.3, issue.11, pp.359-376, 1997.
DOI : 10.1177/096228029700600405

F. Y. Bois, Analysis of PBPK Models for Risk Characterization, Annals of the New York Academy of Sciences, vol.43, issue.9, pp.317-337, 1999.
DOI : 10.1016/0041-008X(90)90037-U
URL : https://hal.archives-ouvertes.fr/ineris-00962759

F. Y. Bois, Statistical Analysis of Clewell et al. PBPK Model of Trichloroethylene Kinetics, Environmental Health Perspectives, vol.108, issue.s2, pp.307-316, 2000.
DOI : 10.1289/ehp.00108s2307
URL : https://hal.archives-ouvertes.fr/ineris-00961854

F. Y. Bois, Statistical Analysis of Fisher et al. PBPK Model of Trichloroethylene Kinetics, Environmental Health Perspectives, vol.108, issue.s2, pp.275-282, 2000.
DOI : 10.1289/ehp.00108s2275
URL : https://hal.archives-ouvertes.fr/ineris-00961853

F. Y. Bois and P. G. Compton-quintana, Sensitivity analysis of a new model of carcinogenesis, Journal of Theoretical Biology, vol.159, issue.3, pp.361-375, 1992.
DOI : 10.1016/S0022-5193(05)80730-1

F. Y. Bois, A. Gelman, J. Jiang, D. Maszle, L. Zeise et al., Population toxicokinetics of tetrachloroethylene, Archives of Toxicology, vol.70, issue.6, pp.347-355, 1996.
DOI : 10.1007/s002040050284
URL : https://hal.archives-ouvertes.fr/ineris-00969532

F. Y. Bois, E. T. Jackson, K. Pekari, and M. T. Smith, Population toxicokinetics of benzene, Environmental Health Perspectives, vol.104, issue.Suppl 6, pp.1405-1411, 1996.
DOI : 10.1289/ehp.961041405

F. Y. Bois, T. J. Smith, A. Gelman, H. Y. Chang, and A. E. Smith, Optimal design for a study of butadiene toxicokinetics in humans, Toxicological Sciences, vol.49, issue.2, pp.213-237, 1999.
DOI : 10.1093/toxsci/49.2.213
URL : https://hal.archives-ouvertes.fr/ineris-00962757

P. Burtin, F. Mentre, J. Vanbree, and J. L. Steimer, Sparse sampling for assessment of drug exposure in toxicological studies, European Journal of Drug Metabolism and Pharmacokinetics, vol.12, issue.2, pp.105-111, 1996.
DOI : 10.1007/BF03190258

D. A. Dankovic and A. J. Bailer, The Impact of Exercise and Intersubject Variability on Dose Estimates for Dichloromethane Derived from a Physiologically Based Pharmacokinetic Model, Fundamental and Applied Toxicology, vol.22, issue.1, pp.20-25, 1994.
DOI : 10.1006/faat.1994.1003

M. Davidian and A. R. Gallant, Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine, Journal of Pharmacokinetics and Biopharmaceutics, vol.11, issue.60, pp.529-56, 1992.
DOI : 10.1007/BF01061470

M. Davidian and D. Giltinian, Nonlinear Models for Repeated Measurements Data, 1995.

P. O. Droz, M. M. Wu, and W. G. Cumberland, Variability in biological monitoring of organic solvent exposure. II. Application of a population physiological model., Occupational and Environmental Medicine, vol.46, issue.8, pp.547-558, 1989.
DOI : 10.1136/oem.46.8.547

M. L. Gargas, M. A. Medinsky, and M. E. Andersen, Pharmacokinetic Modeling Approaches for Describing the Uptake, Systemic Distribution, and Disposition of Inhaled Chemicals, Critical Reviews in Toxicology, vol.150, issue.3, pp.237-254, 1995.
DOI : 10.1080/15287399109531480

A. Gelman, F. Y. Bois, and J. Jiang, Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions, Journal of the American Statistical Association, vol.55, issue.436, pp.1400-1412, 1996.
DOI : 10.2307/2533402

A. Gelman and D. B. Rubin, Markov chain Monte Carlo methods in biostatistics, Statistical Methods in Medical Research, vol.80, issue.4, pp.339-55, 1996.
DOI : 10.1177/096228029600500402

P. G. Georgopoulos, A. Roy, and M. A. Gallo, Reconstruction of short-term multi-route exposure to volatile organic compounds using physiologically based pharmacokinetic models, J. Exposure Anal. Environ. Epidemiol, vol.4, pp.309-328, 1994.

W. R. Gilks, S. Richardson, and D. J. Spiegelhalter, Markov Chain Monte Carlo in Practice, 1996.

G. Johanson, F. Jonsson, and F. Y. Bois, Development of new technique for risk assessment using physiologically based toxicokinetic models, American Journal of Industrial Medicine, vol.5, issue.S1, pp.101-103, 1999.
DOI : 10.1002/(SICI)1097-0274(199909)36:1+<101::AID-AJIM36>3.0.CO;2-I
URL : https://hal.archives-ouvertes.fr/ineris-00962758

M. C. Kohn, Achieving credibility in risk assessment models, Toxicology Letters, vol.79, issue.1-3, pp.107-114, 1995.
DOI : 10.1016/0378-4274(95)03362-O

D. J. Lunn and L. J. Aarons, Markov Chain Monte Carlo Techniques for Studying Interoccasion and Intersubject Variability: Application to Pharmacokinetic Data, Journal of the Royal Statistical Society: Series C (Applied Statistics), vol.46, issue.1, pp.73-91, 1997.
DOI : 10.1111/1467-9876.00048

A. Mallet, F. Mentre, J. L. Steimer, and F. Lokiec, Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine, Journal of Pharmacokinetics and Biopharmaceutics, vol.14, issue.3, pp.311-338, 1988.
DOI : 10.1007/BF01062140

K. S. Mccann, The diversity???stability debate, Nature, vol.405, issue.6783, pp.228-233, 2000.
DOI : 10.1038/35012234

Y. Merlé and F. Mentré, Bayesian design criteria: Computation, comparison, and application to a pharmacokinetic and a pharmacodynamic model, Journal of Pharmacokinetics and Biopharmaceutics, vol.19, issue.1, pp.101-125, 1995.
DOI : 10.1007/BF02353788

J. B. Morris, D. E. Robinson, T. A. Vollmuth, R. P. Brown, and B. E. Domeyer, A Parallelogram Approach for Safety Evaluation of Ingested Acetaldehyde, Regulatory Toxicology and Pharmacology, vol.24, issue.3, pp.251-63, 1996.
DOI : 10.1006/rtph.1996.0138

J. L. Palmer and P. Müller, Bayesian optimal design in population models for haematologic data, Statistics in Medicine, vol.17, issue.14, pp.1613-1622, 1998.
DOI : 10.1002/(SICI)1097-0258(19980730)17:14<1613::AID-SIM867>3.0.CO;2-C

F. Patron-bizet, F. Mentré, M. Genton, C. Thomas-haimez, and J. Maccario, Assessment of the global two-stage method to EC50 determination, Journal of Pharmacological and Toxicological Methods, vol.39, issue.2, pp.103-108, 1998.
DOI : 10.1016/S1056-8719(98)00014-8

A. Racine-poon, A Bayesian Approach to Nonlinear Random Effects Models, Biometrics, vol.41, issue.4, pp.1015-1023, 1985.
DOI : 10.2307/2530972

A. Racine-poon and A. F. Smith, Population Models, Statistical Methodology in the Pharmaceutical Sciences, pp.139-162, 1990.
DOI : 10.1201/b16950-6

W. D. Rowe, Understanding Uncertainty, Risk Analysis, vol.14, issue.5, pp.743-750, 1994.
DOI : 10.1111/j.1539-6924.1994.tb00284.x

G. A. Seber and C. J. Wild, Nonlinear Regression, 1989.
DOI : 10.1002/0471725315

L. B. Sheiner, The Population Approach to Pharmacokinetic Data Analysis: Rationale and Standard Data Analysis Methods, Drug Metabolism Reviews, vol.27, issue.1-2, pp.153-171, 1984.
DOI : 10.1214/aoms/1177706645

L. B. Sheiner and T. M. Ludden, Population Pharmacokinetics/Dynamics*, Annual Review of Pharmacology and Toxicology, vol.32, issue.1, pp.185-209, 1992.
DOI : 10.1146/annurev.pa.32.040192.001153

C. D. Sherman and C. J. Portier, Calculation of the Cumulative Distribution Function of the Time to a Small Observable Tumor, Bulletin of Mathematical Biology, vol.62, issue.2, pp.229-240, 2000.
DOI : 10.1006/bulm.1999.0148

A. Stirling, On science and precaution in the management of technological risk ? Final report and summary of the study conducted under the auspices of an ESTO project on technological risk and the management of uncertainty, 1999.

W. Y. Tan, Stochastic Models of Carcinogenesis, 1991.
DOI : 10.1142/9789814390958_0010

K. Thomaseth and A. Salvan, Estimation of occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin using a minimal physiologic toxicokinetic model, Environmental Health Perspectives, vol.106, issue.Suppl 2, pp.743-53, 1998.
DOI : 10.1289/ehp.98106743

S. Vozeh, J. L. Steimer, M. Rowland, P. Morselli, F. Mentre et al., The Use of Population Pharmacokinetics in Drug Development, Clinical Pharmacokinetics, vol.30, issue.2, pp.81-93, 1996.
DOI : 10.2165/00003088-199630020-00001

J. C. Wakefield, An Expected Loss Approach to the Design of Dosage Regimens Via Sampling-Based Methods, The Statistician, vol.43, issue.1, pp.13-29, 1994.
DOI : 10.2307/2348929

J. C. Wakefield, The Bayesian Analysis of Population Pharmacokinetic Models, Journal of the American Statistical Association, vol.86, issue.433, pp.62-75, 1996.
DOI : 10.1080/01621459.1996.10476664

J. C. Wakefield, A. F. Smith, A. Racine-poon, and A. E. Gelfand, Bayesian analysis of linear and nonlinear population models by using the Gibbs sampler, Appl. Statist. ? J. Roy. Statist. Soc. C, vol.43, pp.201-221, 1994.

T. J. Woodruff, F. Y. Bois, D. Auslander, and R. C. Spear, Structure and Parameterization of Pharmacokinetic Models: Their Impact on Model Predictions, Risk Analysis, vol.8, issue.2, pp.189-201, 1992.
DOI : 10.1016/0378-4274(91)90157-2

L. Yuh, S. Beal, M. Davidian, F. Harrison, A. Hester et al., Population Pharmacokinetic/Pharmacodynamic Methodology and Applications: A Bibliography, Biometrics, vol.50, issue.2, pp.566-575, 1994.
DOI : 10.2307/2533402